Unknown

Dataset Information

0

Successive remodeling of IgG glycans using a solid-phase enzymatic platform.


ABSTRACT: The success of glycoprotein-based drugs in various disease treatments has become widespread. Frequently, therapeutic glycoproteins exhibit a heterogeneous array of glycans that are intended to mimic human glycopatterns. While immunogenic responses to biologic drugs are uncommon, enabling exquisite control of glycosylation with minimized microheterogeneity would improve their safety, efficacy and bioavailability. Therefore, close attention has been drawn to the development of glycoengineering strategies to control the glycan structures. With the accumulation of knowledge about the glycan biosynthesis enzymes, enzymatic glycan remodeling provides a potential strategy to construct highly ordered glycans with improved efficiency and biocompatibility. In this study, we quantitatively evaluate more than 30 enzymes for glycoengineering immobilized immunoglobulin G, an impactful glycoprotein class in the pharmaceutical field. We demonstrate successive glycan remodeling in a solid-phase platform, which enabled IgG glycan harmonization into a series of complex-type N-glycoforms with high yield and efficiency while retaining native IgG binding affinity.

SUBMITTER: Hsu YP 

PROVIDER: S-EPMC8990068 | biostudies-literature | 2022 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Successive remodeling of IgG glycans using a solid-phase enzymatic platform.

Hsu Yen-Pang YP   Verma Deeptak D   Sun Shuwen S   McGregor Caroline C   Mangion Ian I   Mann Benjamin F BF  

Communications biology 20220407 1


The success of glycoprotein-based drugs in various disease treatments has become widespread. Frequently, therapeutic glycoproteins exhibit a heterogeneous array of glycans that are intended to mimic human glycopatterns. While immunogenic responses to biologic drugs are uncommon, enabling exquisite control of glycosylation with minimized microheterogeneity would improve their safety, efficacy and bioavailability. Therefore, close attention has been drawn to the development of glycoengineering str  ...[more]

Similar Datasets

| S-EPMC5877797 | biostudies-literature
| S-EPMC10901958 | biostudies-literature
| S-EPMC9043567 | biostudies-literature
| S-EPMC8718214 | biostudies-literature
| S-EPMC7756758 | biostudies-literature
| S-EPMC5691330 | biostudies-literature
| S-EPMC6926425 | biostudies-literature
| S-EPMC3156280 | biostudies-literature
| S-EPMC4279165 | biostudies-literature
| S-BSST309 | bioimages